tiprankstipranks
Trending News
More News >
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Canadian Market

ME Therapeutics Holdings, Inc. (METX) Financial Statements

Compare
10 Followers

ME Therapeutics Holdings, Inc. Financial Overview

ME Therapeutics Holdings, Inc.'s market cap is currently C$88.77M. The company's EPS TTM is C$-0.011; its P/E ratio is -70.09; ME Therapeutics Holdings, Inc. is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24Aug 23Sep 22
Income Statement
Total Revenue
Gross Profit---
Operating Income$ -1.37M$ -6.54M$ -60.28K
EBITDA$ -1.29M$ -6.51M$ -57.46K
Net Income$ -1.29M$ -6.52M$ -57.46K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 1.54M$ 671.86K$ 397.91K
Total Debt$ 0.00$ 40.00K$ 0.00
Net Debt$ -1.50M$ -607.14K$ -397.91K
Total Liabilities$ 62.92K$ 148.47K$ 35.37K
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -657.92K$ -303.19K-
Operating Cash Flow$ -657.92K$ -303.19K$ -22.09K
Investing Cash Flow
Financing Cash Flow
Currency in USD

ME Therapeutics Holdings, Inc. Earnings and Revenue History

ME Therapeutics Holdings, Inc. Debt to Assets

ME Therapeutics Holdings, Inc. Cash Flow

ME Therapeutics Holdings, Inc. Forecast EPS vs Actual EPS